Abstract

BackgroundCertolizumab pegol (CZP) is a PEGylated Fc-free anti-TNF that improves patient-reported outcomes (PROs) in rheumatoid arthritis.1 The efficacy and safety of CZP in psoriatic arthritis (PsA) has been investigated in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24‐Week Patient‐Reported Outcome Results of a Phase III, Multicenter Study
D Gladman ... P J Mease
Arthritis Care and Research | VOL. 66
D Gladman, et. al.D Gladman ... P J Mease
26 Jun 2014
AB0792 NETAKIMAB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PHASE 3 TRIAL (PATERA)
T Korotaeva ... I Gaydukova
-
T Korotaeva, et. al.T Korotaeva ... I Gaydukova
01 Jun 2020
THU0433 Secukinumab Improves Physical Function, Quality of Life, Fatigue and Work Productivity in Patients with Active Psoriatic Arthritis in Future 2, A Phase 3 Trial
P Rahman ... E Dokoupilová
Annals of the Rheumatic Diseases | VOL. 74
P Rahman, et. al.P Rahman ... E Dokoupilová
01 Jun 2015
AB1088 EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY
I Mcinnes ... J Curtis
Annals of the Rheumatic Diseases | VOL. 82
I Mcinnes, et. al.I Mcinnes ... J Curtis
30 May 2023
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens
Lieve Van Hoovels ... Xavier Bossuyt
Annals of the Rheumatic Diseases | VOL. -
Lieve Van Hoovels, et. al.Lieve Van Hoovels ... Xavier Bossuyt
23 Jul 2024
Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?
Elise Van Mulligen ... Annette Van Der Helm-Van Mil
Annals of the Rheumatic Diseases | VOL. -
Elise Van Mulligen, et. al.Elise Van Mulligen ... Annette Van Der Helm-Van Mil
17 Jul 2024
Racial variability in immune responses only partially explains differential systemic sclerosis disease severity
Kamini E Kuchinad ... Ami A Shah
Annals of the Rheumatic Diseases | VOL. -
Kamini E Kuchinad, et. al.Kamini E Kuchinad ... Ami A Shah
17 Jul 2024
Altered CD8+ T cell subpopulation in the bone marrow microenvironment of cynomolgus monkeys with spontaneous ankylosing spondylitis
Tangming Guan ... Wende Li
Annals of the Rheumatic Diseases | VOL. -
Tangming Guan, et. al.Tangming Guan ... Wende Li
17 Jul 2024
View more papers